Veeva Systems (VEEV) Stock Forecast & Price Target

$240.74 +1.70 (+0.71%)

As of 01:54 PM Eastern

Veeva Systems - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 25 Analyst Ratings

Sell
2

Hold
8

Buy
15

Based on 25 Wall Street analysts who have issued ratings for Veeva Systems in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 25 analysts, 2 have given a sell rating, 8 have given a hold rating, and 15 have given a buy rating for VEEV.

Consensus Price Target

$256.52
6.56% Upside

According to the 25 analysts' twelve-month price targets for Veeva Systems, the average price target is $256.52. The highest price target for VEEV is $307.00, while the lowest price target for VEEV is $192.00. The average price target represents a forecasted upside of 6.56% from the current price of $240.74.

Get the Latest News and Ratings for VEEV and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Veeva Systems and its competitors.

VEEV Analyst Ratings Over Time

Type	Current Forecast 3/25/24 to 3/25/25	1 Month Ago 2/24/24 to 2/23/25	3 Months Ago 12/26/23 to 12/25/24	1 Year Ago 3/26/23 to 3/25/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	15 Buy rating(s)	16 Buy rating(s)	18 Buy rating(s)	14 Buy rating(s)
Hold	8 Hold rating(s)	8 Hold rating(s)	8 Hold rating(s)	5 Hold rating(s)
Sell	2 Sell rating(s)	2 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$256.52	$255.08	$257.44	$231.90
Forecasted Upside	6.56% Upside	12.82% Upside	18.40% Upside	1.10% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

Remove Ads

VEEV Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

VEEV Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Veeva Systems Stock vs. The Competition

Type	Veeva Systems	Medical Companies	S&P 500
Consensus Rating Score	2.52	2.82	2.54
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	5.19% Upside	21,715.17% Upside	17.16% Upside
News Sentiment Rating	Positive News See Recent VEEV News	Positive News	Positive News

Remove Ads

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
3/20/2025	JPMorgan Chase & Co. 3 of 5 stars	Anne Samuel Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Neutral ➝ Neutral	$218.00 ➝ $249.00	+5.30%
3/6/2025	Scotiabank 5 of 5 stars	A. Verkhovski Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Sector Perform ➝ Sector Perform	$240.00 ➝ $245.00	+3.61%
3/6/2025	Truist Financial 2 of 5 stars	Joe Meares Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Hold ➝ Hold	$210.00 ➝ $217.00	-8.24%
3/6/2025	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Garro Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$280.00 ➝ $280.00	+19.63%
3/6/2025	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Craig Hettenbach Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Underweight ➝ Underweight	$195.00 ➝ $201.00	-8.77%
3/6/2025	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ryan MacDonald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$270.00 ➝ $270.00	+22.55%
3/6/2025	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joe Vruwink Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$283.00 ➝ $285.00	+29.36%
1/23/2025	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Gabriela Borges Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Sell	$261.00 ➝ $200.00	-12.68%
1/8/2025	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$285.00 ➝ $255.00	+17.46%
12/9/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$281.00 ➝ $307.00	+22.77%
Get the Latest News and Ratings for VEEV and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Veeva Systems and its competitors with MarketBeat's FREE daily newsletter.
12/6/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$260.00 ➝ $275.00	+9.86%
12/6/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	In-Line ➝ In-Line	$220.00 ➝ $245.00	-4.09%
12/6/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$280.00 ➝ $290.00	+13.44%
12/6/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$275.00 ➝ $285.00	+12.20%
12/6/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$275.00 ➝ $285.00	+23.03%
12/6/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$240.00 ➝ $272.00	+17.41%
12/6/2024	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$210.00 ➝ $270.00	+16.55%
12/6/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$280.00 ➝ $290.00	+25.18%
12/4/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Valiquette Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform ➝ Outperform	$275.00 ➝ $275.00	+21.44%
10/8/2024	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Degasperi Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$286.00	+41.70%
10/1/2024	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$233.00 ➝ $249.00	+20.00%
8/29/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$180.00 ➝ $192.00	-11.20%
8/29/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$230.00 ➝ $235.00	+12.28%
8/26/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$185.00 ➝ $215.00	+7.47%
7/9/2024	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Larsen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$240.00	+31.21%
3/4/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$225.00 ➝ $270.00	+21.62%
2/22/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$225.00	+2.46%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 01:55 PM ET.

Should I Buy Veeva Systems Stock? VEEV Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, March 14, 2025. Please send any questions or comments about these Veeva Systems pros and cons to contact@marketbeat.com.

Veeva Systems
Bull Case

Here are some ways that investors could benefit from investing in Veeva Systems Inc.:

The current stock price is around $255.28, which is close to the consensus target price, indicating potential for growth as analysts have a generally positive outlook.
Veeva Systems Inc. has a strong market capitalization of $37.88 billion, suggesting stability and a solid position in the market, which can be attractive to investors looking for reliable companies.
The company has received multiple "buy" ratings from analysts, with 16 out of 26 analysts recommending buying the stock, reflecting confidence in its future performance.
Recent price target upgrades from various analysts, including a boost to $290.00 from Bank of America, indicate that experts see significant upside potential in the stock.
Veeva Systems Inc. operates in the growing life sciences sector, providing cloud-based software solutions, which positions it well to benefit from ongoing advancements in healthcare technology.

Veeva Systems
Bear Case

Investors should be bearish about investing in Veeva Systems Inc. for these reasons:

The stock has a high PE ratio of 57.62, which may indicate that it is overvalued compared to its earnings, making it a riskier investment for those concerned about valuation.
Two analysts have rated the stock with a "sell" rating, suggesting that there are concerns about its future performance that could lead to a decline in stock price.
Goldman Sachs recently downgraded the stock from a "buy" to a "sell" rating, reducing their price target significantly, which may signal potential challenges ahead for the company.
The beta of 0.88 indicates that the stock is less volatile than the market, which may not appeal to investors looking for high-risk, high-reward opportunities.
Despite a generally positive outlook, the mixed ratings from analysts, with a significant number of hold ratings, suggest uncertainty about the stock's short-term performance.

VEEV Forecast - Frequently Asked Questions

: According to the research reports of 25 Wall Street equities research analysts, the average twelve-month stock price forecast for Veeva Systems is $256.52, with a high forecast of $307.00 and a low forecast of $192.00.
: 25 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Veeva Systems in the last year. There are currently 2 sell ratings, 8 hold ratings and 15 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" VEEV shares.
: According to analysts, Veeva Systems's stock has a predicted upside of 6.56% based on their 12-month stock forecasts.
: Over the previous 90 days, Veeva Systems's stock had 1 downgrade by analysts.
: Veeva Systems has been rated by research analysts at JPMorgan Chase & Co., KeyCorp, Morgan Stanley, Needham & Company LLC, Robert W. Baird, Scotiabank, Stephens, The Goldman Sachs Group, and Truist Financial in the past 90 days.
: Analysts like Veeva Systems less than other "medical" companies. The consensus rating score for Veeva Systems is 2.52 while the average consensus rating score for "medical" companies is 2.82. Learn more on how VEEV compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:VEEV) was last updated on 3/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Veeva Systems (VEEV) Stock Forecast & Price Target